Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

Variables and prognosis were analysed based on the presence or absence of NCA, defined as previous stroke, transient ischaemic attack (TIA), or peripheral artery disease (PAD) [lower extremity artery disease (LEAD), carotid disease, previous lower limb vascular surgery, or abdominal aortic aneurysm (AAA)].

Coronary Artery Bypass Graft 64

Coronary Artery Bypass Graft Atherosclerosis Peripheral Arterial Disease Coronary Artery Disease 64

Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Results Brandenburg patients with cardiovascular diseases showed higher Lp(a) levels than healthy controls (24.2% vs. 14.8%, p  = 0.001), and the high-Lp(a) group demonstrated a higher prevalence of coronary artery disease, peripheral artery disease, or cerebrovascular disease than the low-Lp(a) group ( p  = 0.004).

Risk Factors 59

Risk Factors Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease 59

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 6, 2024

Self-reported smoking status was assessed at each consecutive visit and used to determine smoking cessation after each interim ASCVD event (myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft, stroke/transient ischemic attack, peripheral artery disease).

Coronary Artery Bypass Graft 45

Coronary Artery Bypass Graft Outpatient Peripheral Arterial Disease Cardiovascular Disease 45

Circulation

OCTOBER 18, 2023

BACKGROUND:Rivaroxaban plus aspirin compared with aspirin alone reduced major cardiac and ischemic limb events after lower extremity revascularization (LER) in the VOYAGER PAD (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease) trial.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Myocardial Infarction Thrombolysis Ischemia 40

Journal of the American Heart Association

MARCH 4, 2025

In the setting of arrhythmias, specific SDoHs can increase the incidence of atrial fibrillation and adversely affect major outcomes in these patients.

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Congenital Heart Disease Coronary Artery Disease 40

The British Journal of Cardiology

AUGUST 1, 2024

Large-scale observational data have demonstrated a robust, independent association of elevated lipoprotein(a) (Lp[a]) levels with atherosclerotic cardiovascular disease (CVD), stroke, and peripheral artery disease.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Myocardial Infarction Plaque Cardiovascular Disease 40

Open Heart

OCTOBER 17, 2022

With the development of Lp(a)-lowering therapies, this study sought to characterise patterns of Lp(a) levels in a global ASCVD population and identify racial, ethnic, regional and gender differences.

Cardiovascular Disease 52

Cardiovascular Disease Peripheral Arterial Disease Myocardial Infarction Cholesterol 52

DAIC

MAY 30, 2024

clinical success (primary safety and effectiveness) with 100% angiographic success across a broad range of moderate to severe calcium morphologies including eccentric, concentric, and nodular calcifications - - Excellent safety with only one peri-procedural non-Q-wave myocardial infarction resulting in a 1.7%

Stents 105

Stents Stent Peripheral Arterial Disease Cardiovascular Disease 105

European Journal of Heart Failure

DECEMBER 10, 2024

Aims Patients experiencing ischaemic heart failure with reduced ejection fraction (HFrEF) represent a diverse group.

Heart Failure 40

Heart Failure Peripheral Arterial Disease Blood Pressure Atrial Fibrillation 40

Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2024

Patients with a new or recurrent episode of ASCVD (angina, acute myocardial infarction, transient ischemic attack, stroke, or peripheral arterial disease) between 1-Jan-2017 and 31-Dec-2018 were included.

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Drug Costs Myocardial Infarction 45

Heart BMJ

MARCH 12, 2024

Methods Inclusion and exclusion criteria of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS), Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA), Prevention of Cardiovascular events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background (..)

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease Myocardial Infarction 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

This unique case highlights the diagnostic and therapeutic challenges of a patient with multiple vascular risk factors who suffered from strokes secondary to BHS.MethodsA 79‐year‐old man with a past medical history of peripheral artery disease, abdominal aortic aneurysm, myocardial infarction with drug eluding stents (on dual antiplatelet therapy (DAPT)), (..)

Stenosis 40

Stenosis Peripheral Arterial Disease Pacemaker Atherosclerosis 40

Dr. Anish Koka

MAY 16, 2023

years of age, P <0.001), cerebral or peripheral artery disease (6.2% Women also had more cardiovascular risk factors, including hypertension (66.6% versus 63.2%; P <0.001), hyperlipidemia (68.9% versus 66.3%; P =0.004), older age (62.4±7.9 years of age versus 59.0±8.4 versus 43.4%; P <0.001).

Chest Pain 52

Chest Pain Coronary Artery Disease Cancer Heart Attack 52

Open Heart

MARCH 22, 2025

Poisson regressions with robust standard errors were used to examine the relative change in event rates over time, overall and by subgroup.

Cardiovascular Disease 52

Cardiovascular Disease Peripheral Arterial Disease Myocardial Infarction Atrial Fibrillation 52

Hypertension Journal

DECEMBER 28, 2023

The noradrenergic phenotype had significantly more atherosclerotic complications (composite end point of type 1 myocardial infarction and symptomatic peripheral artery disease; odds ratio, 3.58 [95% CI, 1.59–8.83];P=0.003), 0.57];P=0.002).

Peripheral Arterial Disease 81

Peripheral Arterial Disease Myocardial Infarction Cardiomyopathy Risk Factors 81

Cardiometabolic Health Congress

DECEMBER 7, 2023

AF is associated with an increased risk of death as well as multiple adverse outcomes, including stroke, cognitive impairment or dementia, myocardial infarction, sudden cardiac death, heart failure (HF), chronic kidney disease (CKD), and peripheral artery disease (PAD).

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Strokes 111